10 Erectile Dysfunction Clinical Trials in Glendale, CA (2026)

Q: How do I join a clinical trial in Glendale?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Glendale research site will contact you.

Recruiting Erectile Dysfunction Studies in Glendale

NCT06480383Recruiting

Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder

This is a multicenter, randomized, double-blind, placebo-controlled study evaluating the efficacy, safety, and tolerability of ITI-1284 compared with placebo as adjunctive therapy to GAD treatment in ...

Glendale, CAPHASE2705 participantsIntra-Cellular Therapies, Inc.

View Study Details

NCT06990399Recruiting

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PEAK

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants with Macular Edema Secondary to Inflammation (MESI)...

Glendale, CAPHASE3600 participantsKodiak Sciences Inc

View Study Details

NCT03093116Recruiting

A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements

Phase 1 dose escalation will determine the first cycle dose-limiting toxicities (DLTs), the maximum tolerated dose (MTD), the biologically effective dose and recommended Phase 2 dose (RP2D) of repotre...

Glendale, CAPHASE1500 participantsTurning Point Therapeutics, Inc.

View Study Details

NCT06380751Recruiting

Saruparib (AZD5305) Plus Camizestrant Compared With CDK4/6 Inhibitor Plus Endocrine Therapy or Plus Camizestrant in HR-Positive, HER2-Negative (IHC 0, 1+, 2+/ ISH Non-amplified), BRCA1, BRCA2, or PALB2m Advanced Breast Cancer

The primary objective of the study is to measure efficacy of saruparib (AZD5305) plus camizestrant compared with physician's choice CDK4/6i plus ET in patients with BRCA1, BRCA2, or PALB2m, HR-positiv...

Glendale, CAPHASE3500 participantsAstraZeneca

View Study Details

NCT07503886Recruiting

An Exploratory Efficacy and Safety Study of DFL24498 Topical Ophthalmic Solution Compared With Vehicle in Participants With Dry Eye Disease

This is a Phase 2, randomized, multicenter, double masked, vehicle controlled, parallel group study to evaluate the efficacy and safety of DFL24498 topical ophthalmic solution versus vehicle in partic...

Glendale, CAPHASE2417 participantsDompé Farmaceutici S.p.A

View Study Details

NCT06996080Recruiting

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLE

A Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants with Macular Edema Secondary to Inflammation (MESI)...

Glendale, CAPHASE3300 participantsKodiak Sciences Inc

View Study Details

NCT07449936Recruiting

COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME

This is a phase 3 randomized, double -masked study comparing the efficacy of EYP-1901 against Aflibercept....

Glendale, CAPHASE3240 participantsEyePoint Pharmaceuticals, Inc.

View Study Details

NCT07205887Recruiting

A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO

EYE-RES-104 is a randomized, dose-masked study of intravitreal EYE103 in participants with neovascular age-related macular degeneration (NVAMD) or macular edema following branch retinal vein occlusion...

Glendale, CAPHASE2160 participantsEyeBiotech Ltd.

View Study Details

NCT07548632Recruiting

A Clinical Study Evaluating Licaminlimab for Dry Eye Disease

The primary objective of this study is to evaluate the efficacy and safety of the topical ophthalmic administration of licaminlimab as compared to vehicle in participants with Dry Eye Disease and a sp...

Glendale, CAPHASE2160 participantsOculis

View Study Details

NCT06811909Recruiting

Non-healing Venous Leg Ulcers Treated With Standard Care With or Without BR-AC

This study examines a patient population with a non-healing, non-infected venous leg ulcer (VLU) having adequate arterial perfusion with confirmed venous reflux. It is hypothesized that weekly applica...

Glendale, CANA60 participantsBioStem Technologies

View Study Details

About Erectile Dysfunction Clinical Trials in Glendale

Erectile dysfunction is the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. It affects about 30 million men in the U.S. and is often a sign of underlying cardiovascular disease. Treatment includes PDE5 inhibitors, vacuum devices, and penile implants.

There are currently 10 erectile dysfunction clinical trials recruiting participants in Glendale, CA. These studies are seeking a combined 3,642 participants. Research is being sponsored by Intra-Cellular Therapies, Inc., Kodiak Sciences Inc, Turning Point Therapeutics, Inc. and 6 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Erectile Dysfunction Clinical Trials in Glendale — FAQ

Are there erectile dysfunction clinical trials in Glendale?

Yes, there are 10 erectile dysfunction clinical trials currently recruiting in Glendale, CA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Glendale?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Glendale research site will contact you about next steps.

Are clinical trials in Glendale free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Glendale studies also compensate for your time and travel.

What erectile dysfunction treatments are being tested?

The 10 active trials in Glendale are testing new therapies including novel drugs, biologics, and treatment approaches for erectile dysfunction.

Data updated July 22, 2026 from ClinicalTrials.gov